Alexandre Favereaux Selected Research

L-Type Calcium Channels (Dihydropyridine Receptor)

1/2017	Group I metabotropic glutamate receptor plasticity after peripheral inflammation alters nociceptive transmission in the dorsal of the spinal cord in adult rats.
11/2016	Cav1.2 and Cav1.3 L-type calcium channels independently control short- and long-term sensitization to pain.
7/2011	Bidirectional integrative regulation of Cav1.2 calcium channel by microRNA miR-103: role in pain.
1/2010	Knockdown of L calcium channel subtypes: differential effects in neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexandre Favereaux Research Topics

Disease

11	Pain (Aches) 01/2020 - 01/2010
5	Neuralgia (Stump Neuralgia) 01/2020 - 01/2010
4	Chronic Pain 12/2017 - 01/2010
4	Neoplasms (Cancer) 01/2017 - 12/2006
2	Inflammation (Inflammations) 01/2018 - 01/2017
2	Glioma (Gliomas) 12/2013 - 08/2010
1	COVID-19 01/2021
1	Pathologic Processes 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Neuroinflammatory Diseases 01/2017
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Hyperalgesia 01/2017
1	Cancer Pain 01/2017
1	Complex Regional Pain Syndromes 10/2013
1	Migraine Disorders (Migraine) 10/2013
1	Ischemia 08/2010
1	Glioblastoma (Glioblastoma Multiforme) 01/2006
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 05/2004
1	Sporadic Creutzfeldt-Jakob Disease 05/2004
1	Proteinuria 04/2003
1	Multiple Myeloma 04/2003
1	Amyloid Plaque 04/2003
1	POEMS Syndrome (Syndrome, POEMS) 01/2003
1	Paraproteinemias (Monoclonal Gammopathy) 01/2003

Drug/Important Bio-Agent (IBA)

6	MicroRNAs (MicroRNA)IBA 01/2019 - 07/2011
5	Analgesics (Analgesic Drugs)IBA 02/2019 - 10/2013
4	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2017 - 01/2010
4	Proteins (Proteins, Gene)FDA Link 12/2013 - 01/2003
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2017
2	EnzymesIBA 01/2017 - 08/2010
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	fibulin 2IBA 01/2020
1	Extracellular Matrix ProteinsIBA 01/2020
1	Cholecystokinin (Pancreozymin)IBA 02/2019
1	NeuropeptidesIBA 02/2019
1	Cholecystokinin B ReceptorIBA 02/2019
1	E 3330IBA 01/2018
1	Freund's AdjuvantIBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	PlatinumIBA 01/2018
1	alpha-SynucleinIBA 01/2017
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2017
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2017
1	EpiregulinIBA 12/2013
1	Biological ProductsIBA 12/2013
1	Epidermal Growth Factor (EGF)IBA 12/2013
1	LigandsIBA 12/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2013
1	ErbB Receptors (EGF Receptor)IBA 12/2013
1	neuroligin 2IBA 11/2013
1	Biomarkers (Surrogate Marker)IBA 10/2013
1	Macromolecular SubstancesIBA 10/2013
1	L-type calcium channel alpha(1C)IBA 07/2011
1	DecorinIBA 08/2010
1	Inositol (Myoinositol)IBA 08/2010
1	Interleukin-6 (Interleukin 6)IBA 08/2010
1	Interleukin-8 (Interleukin 8)IBA 08/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2010
1	CalciumIBA 01/2010
1	Calcium Channels (Calcium Channel)IBA 01/2010
1	Peptide Nucleic AcidsIBA 01/2010
1	Phosphotransferases (Kinase)IBA 01/2006
1	DNA (Deoxyribonucleic Acid)IBA 01/2006
1	Codon (Codons)IBA 01/2006
1	Prion ProteinsIBA 05/2004
1	Peptide Hydrolases (Proteases)FDA Link 05/2004
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 04/2003
1	Congo RedIBA 04/2003
1	Prealbumin (Transthyretin)IBA 04/2003
1	thioflavin TIBA 04/2003
1	Immunoglobulin M (IgM)IBA 01/2003
1	Myelin-Associated GlycoproteinIBA 01/2003

Therapy/Procedure

2	Spinal Injections 01/2018 - 01/2017
2	Analgesia 01/2017 - 10/2013
2	Ligation 11/2013 - 01/2010
1	Therapeutics 12/2017
1	Pain Management 12/2017
1	Radiotherapy 01/2006